|
Jun 18
|
‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
|
|
Jun 18
|
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
|
|
Jun 18
|
Charles River and Captain T Cell sign vector production agreement
|
|
Jun 17
|
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
|
|
May 30
|
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
|
|
May 30
|
Reasons to Hold Charles River (CRL) in Your Portfolio Now
|
|
May 24
|
Charles River (CRL) Banks on RMS Growth Amid Competition
|
|
May 14
|
Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
|
|
May 13
|
Don't Overlook Charles River (CRL) International Revenue Trends While Assessing the Stock
|
|
May 13
|
Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term
|
|
May 10
|
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
|
|
May 10
|
Q1 2024 Charles River Laboratories International Inc Earnings Call
|
|
May 9
|
Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
|
|
May 9
|
Charles River (CRL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 9
|
Charles River beats first-quarter estimates, reaffirms annual forecast
|
|
May 9
|
Charles River Laboratories Announces First-Quarter 2024 Results
|
|
May 8
|
The 7 Best Growth Stocks to Buy in May 2024
|
|
May 6
|
Charles River (CRL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
|
May 2
|
Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates
|